A vs GEHC
A: A diversified healthcare and life sciences company providing analytical instruments, software, and services for pharmaceutical, chemical, and clinical diagnostics laboratories worldwide. GEHC: GE HealthCare is a leading medical technology company providing advanced diagnostic imaging, patient monitoring, and AI-driven clinical software to help clinicians manage complex diseases.
Side-by-side fundamentals
| Metric | A | GEHC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $133.46 | $61.41 | |
| Market cap as of 2026-07-23 | $37.6B | $27.9B | |
| P/E as of 2026-07-23 | 26.62 | 14.63 | GEHC lower |
| PEG as of 2026-07-23 | 3.24 | 2.18 | GEHC lower |
| Net margin as of 2026-07-23 | +19.6% | +9.1% | A higher |
| Gross margin as of 2026-07-23 | +52.9% | +39.1% | A higher |
| Operating margin as of 2026-07-23 | +21.5% | +12.6% | A higher |
| ROE as of 2026-07-23 | +20.8% | +18.8% | A higher |
| ROA as of 2026-07-23 | +11.1% | +5.3% | A higher |
| Debt / equity as of 2026-07-23 | 0.47 | 0.95 | A lower |
| Revenue growth (YoY) as of 2026-07-23 | +9.1% | +6.0% | A higher |
| Revenue CAGR (3y) SEC XBRL | +0.5% | +4.0% | GEHC higher |
| Dividend yield as of 2026-07-23 | +0.8% | +0.2% | A higher |
| Dividend streak (yrs) SEC XBRL | 5 | 3 | A higher |
| Beta as of 2026-07-23 | 1.24 | 0.84 | |
| 1-year return as of 2026-07-22 close | +18.6% | -16.3% | A higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.